About MicroPhage

MicroPhage, Inc., a platform diagnostic technology company, develops medical diagnostics for bacterial identification and antibiotic susceptibility/resistance testing. Its products include methicillin-susceptible Staphylococcus aureus (MSSA)/methicillin-resistant Staphylococcus aureus (MRSA) blood culture tests, MRSA screening tests, and MRSA/MSSA screening tests. The company was founded in 2002 and is based in Longmont, Colorado.

Company Highlights
Year Founded

2002

icon-altEmployees

2

Location (HQ)

USA

Since Last Funding

12 years 10 months

Monthly Website Visitors

1.0K

icon-altTotal Investment Amt

$15M

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Similar Companies

Biotechnology

Health Diagnostics

Biotechnology Research

Pharmaceutical